Speakers
Professor Marlies Ostermann
Dr Luke Flower
Dr Catherine McKenzie
Dr Boris Jung
Hall 1
We’re thrilled to introduce brand-new SOA26 content in collaboration with UK Critical Care Research Group (UKCCRG).
Across four compelling sessions on Day 2, leading experts will spotlight landmark recent publications, unpack the underpinning science, and bring the evidence to life by exploring its real-world clinical impact.
This is a must-attend series for anyone passionate about staying at the forefront of critical care research and practice. Featured studies include MARCH, BICARICU-2, Andromeda Shock 2, and iRehab.
BICARICU-2 Learning objectives:
Co-chairs: Luke Flower and Cathy Mckenzie
Marlies is a Consultant in Critical Care & Nephrology at Guy’s & St. Thomas’ Foundation Trust, London and Honorary Senior Lecturer at King’s College London.
Following medical school in Goettingen (Germany), she completed her postgraduate training in the United Kingdom and Canada. She is one of the Directors of Research at the Intensive Care Society, and actively involved in the Renal Association. She is Deputy Chair of the AKI working group of the European Society of Intensive Care Medicine.
Her clinical and research interests include acute kidney injury in the critically ill, including biomarkers and long-term complications, and all aspects related to acute renal replacement therapy.
Dr Flower is a Specialty Registrar in Intensive Care Medicine in London and a PhD student at the University of Cambridge, based at the Victor Phillip Dahdaleh Heart & Lung Research Institute. His doctoral research focuses on mechanisms of immune dysregulation in severe acute hypoxaemic respiratory failure and is supported by Cambridge University's first Centre for Pandemic Risk Management Doctoral Research Fellowship.
His clinical and research interests centre around the pathophysiology and management of ARDS and cardiogenic shock. He has also been involved in several critical care ultrasound initiatives, including leading a large national study investigating echocardiography in shock (NEAT-ECHO) and serving as lead editor of the textbook Point-of-Care Ultrasound in Intensive Care.
Dr Flower currently serves as Co-Chair of the UK Trainee Research in Intensive Care (TRIC) Network, Academic StR Representative to the Faculty of Intensive Care Medicine, and International Subcommittee Lead for the American Thoracic Society Critical Care Assembly’s Early Career Professionals Working Group. He is also an Associate Editor for the Journal of the Intensive Care Society, a member of the Intensive Care Society’s EDI Working Party, and has received the Intensive Care Society's ICU People Champion Award and the Association of Anaesthetists’ Kathleen Ferguson Award for his work addressing health inequity.
Cathy McKenzie is a Professor of Intensive Care Pharmacy in the Faculty of Medicine, University of Southampton, and an Honorary Consultant Pharmacist in Critical Care. She has extensive knowledge and clinical experience of pharmacotherapy in healthcare. Her research interests are pharmacokinetics and pharmacodynamics (PKPD), antimicrobrial stewardship, medicines optimisation and delirium treatment and prevention in critical illness. She is currently funded via a the NIHR (National Institute for Health Research) Senior Clinical Practitioner Research Award. Cathy has recently been awarded £2.74million from NIHR Efficacy Mechanism and Evaluation program to conduct a double blind randomised controlled trial of IV thiamine versus placebo in the prevention and treatment of delirium in ICU. She has led or been a co-applicant of more than £6million in research funding. Cathy is supporting the NHR respiratory metagenomics programme with research into its impact on antimicrobial stewardhip and polypharmacy in ICU.
Cathy is one of three editors in chief for Critical Illness, an internationally acclaimed eBook, published by Pharmaceutical Press (www.medicinescomplete.com)
Professor Lui Forni trained in intensive care and nephrology at St Thomas’ and St George’s Hospitals. He was appointed Professor of Intensive Care Medicine at the Royal Surrey Hospital NHS Foundation Trust in 2014 and joined the new School of Medicine at the University of Surrey in 2023. A founding member of the AKI section of ESICM, he went on to chair the group, later serving as Chair of Research and then Secretary of the Society. He is currently President-Elect of the International Society of Critical Care Nephrology.
His research interests all aspects of acute kidney injury and renal replacement therapy. Professor Forni has also advised NCEPOD, been a faculty member for ADQI, contributed to the NHS England “Think Kidneys” programme, served as an elected member of the Faculty of Intensive Care Medicine, and remains an active member of the UK AKI Clinical Studies Group.
He remains cursed by his support of Tottenham Hotspur and lack of musical ability obvious when you hear him play guitar. Or sing.